Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men

Clinical Science

Volumn 130, Issue 13, 2016, Pages 1105-1114

  Verboven, Kenneth ^a,b   Hansen, Dominique ^b,c   Moro, Cedric ^d,e   Eijnde, Bert O ^b   Hoebers, Nicole ^a   Knol, Joep ^c   Bouckaert, Wim ^c   Dams, Anne ^f   Blaak, Ellen E ^a   Jocken, Johan W E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

^c JESSA HOSPITAL   (Belgium)

^d INSERM   (France)

^e Université de Toulouse   (France)

^f DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Adipose tissue; Diabetes mellitus; Lipolysis; Natriuretic peptides; Obesity; Type 2

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; HEMOGLOBIN A1C; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; SCAVENGER RECEPTOR C;

ADIPOCYTE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; DIABETIC PATIENT; EX VIVO STUDY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTRAPERITONEAL FAT; LIPOLYSIS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; COMPLICATION; CYTOLOGY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; OBESITY; PHYSIOLOGY;

ADIPOCYTES; ADULT; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINES; DIABETES MELLITUS, TYPE 2; HUMANS; LIPOLYSIS; MALE; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT;

EID: 84995747957     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160220     Document Type: Article

References (53)

1. Lafontan, M. (2014) Adipose tissue and adipocyte dysregulation. Diabetes Metab 40, 16-28
2. Virtue, S. and Vidal-Puig, A. (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim. Biophys. Acta 1801, 338-349
3. Karastergiou, K. and Fried, S.K. (2013) Multiple adipose depots increase cardiovascular risk via local and systemic effects. Curr. Atheroscler. Rep. 15, 361
4. Prospective Studies Collaboration, Whitlock, G., Lewington, S., Sherliker, P., Clarke, R., Emberson, J., Halsey, J., Qizilbash, N., Collins, R. and Peto, R. (2009) Body-mass index and cause-specific mortality in 900, 000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083-1096
5. Frayn, K.N. (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201-1210
6. Frühbeck, G., Méndez-Giménez, L., Fernandéz-Formoso, J.A., Fernandéz, S. and Rodriguez, A. (2014) Regulation of adipocyte lipolysis. Nutr. Res. Rev. 27, 63-93
7. Langin, D., Dicker, A., Tavernier, G., Hoffstedt, J., Mairal, A., Ryden, M., Arner, E., Sicard, A., Jenkins, C.M., Viguerie, N. et al. (2005) Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54, 3190-3197
8. Large, V. and Arner, P. (1998) Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab. 24, 409-418
9. McQuaid, S.E., Hodson, L., Neville, M.J., Dennis, A.L., Cheeseman, J., Humphreys, S.M., Ruge, T., Gilbert, M., Fielding, B.A., Frayn, K.N. and Karpe, F. (2011) Downregulation of adipose tissue fatty acid trafficking in obesity - a driver for ectopic fat deposition. Diabetes 60, 47-55
10. Jocken, J.W.E., Goossens, G.H., van Hees, A.M., Frayn, K.N., van Baak, M., Stegen, J., Pakbiers, M.T., Saris, W.H. and Blaak, E.E. (2008) Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologia 51, 320-327
11. Ryden, M., Jocken, J.W.E., van Harmelen, V., Dicker, A., Hoffstedt, J., Wiren, M., Blomqvist, L., Mairal, A., Langin, D., Blaak, E. and Arner, P. (2007) Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis. Am. J. Physiol. Endocrinol. Metab. 292, E1847-E1855
12. Lonnqvist, F., Thome, A., Nilsell, K., Hoffstedt, J. and Arner, P. (1995) A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J. Clin. Invest. 95, 1109-1116
13. Hoffstedt, J., Arner, P., Hellers, G. and Lönnqvist, F. (1997) Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J. Lipid. Res. 38, 795-804
14. Arner, P. (1995) Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med. 27, 435-438
15. Mauriege, P., Depres, J.P., Prud'homme, D., Pouliot, M.C., Marcotte, M., Tremblay, A. and Bouchard, C. (1991) Regional variation in adipose tissue lipolysis in lean and obese men. J. Lipid. Res. 32, 1625-1633
16. Dahlman, I. and Arner, P. (2007) Obesity and polymorphisms in genes regulating human adipose tissue. Int. J. Obes. 31, 1629-1641
17. Terra, S.G., McGorray, S.P., Wu, R., McNamara, D.M., Cavallari, L.H., Walker, J.R., Wallace, M.R., Johnson, B.D., Bairey Merz, C.N., Sopko, G. et al. (2005) Association between b-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int. J. Obes. 29, 746-754
18. Sengenès, C., Berlan, M., De Glisezinski, I., Lafontan, M. and Galitzky, J. (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 14, 1345-1351
19. Galitzky, J., Sengenes, C., Thalamas, C., Marques, M.A., Senard, J.M., Lafontan, M. and Berlan, M. (2001) The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young obese men. J. Lipid. Res. 42, 536-544
20. Birkenfeld, A.L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Franke, G., Berlan, M., Luft, F.C., Lafontan, M. and Jordan, J. (2005) Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J. Clin. Endocrinol. Metab. 90, 3622-3628
21. Birkenfeld, A.L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Tank, J., Diedrich, A., Schroeder, C., Franke, G., Berlan, M. et al. (2006) Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J. Clin. Endocrinol. Metab. 91, 5069-5075
22. Rydén, M., Backdahl, J., Petrus, P., Thorell, A., Gao, H., Coue, M., Langin, D., Moro, C. and Arner, P. (2016) Impaired atrial natriuretic peptide-mediated lipolysis in obesity. Int. J. Obes. 40, 714-720
23. Dicker, A., Aström, G., Wahlen, K., Hoffstedt, J., Naslund, E., Wiren, M., Rydén, M., Arner, P. and van Harmelen, V. (2009) Primary differences in lipolysis between human omental and subcutaneous adipose tissue observed using in vitro differentiated adipocytes. Horm. Metab. Res. 41, 350-355
24. Pivovarova, O., Gögebakan, O., Klöting, N., Sparwasser, A., Weickert, M.O., Haddad, I., Nikiforova, V.J., Bergmann, A., Kruse, M., Seltmann, A.C. et al. (2012) Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J. Clin. Endocrinol. Metab. 97, E731-E739
25. Sengenes, C., Bouloumié, A., Hauner, H., Berlan, M., Busse, R., Lafontan, M. and Galitzky, J. (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J. Biol. Chem. 278, 48617-48626
26. Matsukawa, N., Grzesik, W.J., Takahashi, N., Pandey, K.N., Pang, S., Yamauchi, M. and Smithies, O. (1999) The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. U.S.A. 96, 7403-7406
27. Potter, L.R., Abbey-Hosch, S. and Dickey, D.M. (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47-72
28. Bordicchia, M., Liu, D., Amri, E.Z., Ailhaud, G., Dessi-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R. and Collins, S. (2012) Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122, 1022-1036
29. Sarzani, R., Paci, V.M., Zingaretti, C.M., Pierleoni, C., Cinti, S., Cola, G., Rappelli, A. and Dessì-Fulgheri, P. (1995) Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J. Hypertens. 13, 1241-1246
30. Nakatsuji, H., Maeda, N., Hibuse, T., Hiuge, A., Hirata, A., Kuroda, Y., Kishida, K., Kihara, S., Funahashi, T. and Shimomura, I. (2010) Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. Biochem. Biophys. Res. Commun. 392, 100-105
31. Dessi-Fulgheri, P., Sarzani, R., Tamburrini, P., Moraca, A., Espinosa, E., Cola, G., Giantomassi, L and Rappelli, A. (1997) Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J. Hypertens. 15, 1695-1699
32. Kovacova, Z., Tharp, W.G., Liu, D., Wei, W., Xie, H., Collins, S. and Pratley, R.E. (2016) Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity 24, 820-828
33. Moro, C., Klimcakova, E., Lafontan, M., Berlan, M. and Galitsky, J. (2007) Phosphodieterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis. Br. J. Pharmacol. 152, 1102-1110
34. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. and Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28, 412-419
35. Rodbell, M. (1964) Metabolism of isolated fat cells - effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239, 375-380
36. Moro, C., Galitzky, J., Sengenes, C., Crampes, F., Lafontan, M. and Berlan, M. (2004) Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells. J. Pharmacol. Exp. Ther. 308, 984-992
37. Moro, C., Pasarica, M., Elkind-Hirsch, K. and Redman, L.M. (2009) Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 94, 2579-2586
38. Yu, J., Yu, H.C., Kim, K.A., Kwon, K.B., Park, J.W., Kim, S.Z., Kim, S.H. and Park, B.H. (2008) Differences in the amount of lipolysis induced by atrial natriuretic peptide in small and large adipocytes. J. Pept. Sci. 14, 972-977
39. Laurencikiene, J., Skurk, T., Kulyte, A., Heden, P., Astrom, G., Sjolin, E., Rydén, M., Hauner, H. and Arner, P. (2011) Regulation of lipolysis in small and large fat cells of the same subject. J. Clin. Endocrinol. Metab. 96, E2045-E2049
40. Jocken, J.W., Langin, D., Smit, E., Saris, W.H., Valle, C., Hul, G.B., Holm, C., Arner, P and Blaak, E.E. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J. Clin. Endocrinol. Metab. 92, 2292-2299
41. Reference deleted
42. Ryden, M., Jocken, J., van Harmelen, V., Dicker, A., Hoffstedt, J., Wiren, M., Blomqvist, L., Mairal, A., Langin, D., Blaak, E and Arner, P. (2007) Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis. Am. J. Physiol. Endocrinol. Metab. 292, E1847-E1855
43. Derbyshire, E.R. and Marletta, M.A. (2012) Structure and regulation of soluble guanylate cyclase. Annu. Rev. Biochem. 81, 533-559
44. Leiss, V., Illison, J., Domes, K., Hofmann, F. and Lukowski, R. (2014) Expression of cGMP-dependent protein kinase type I in mature white adipocytes. Biochem. Biophys. Res. Commun. 452, 151-156
45. Hofmann, L.S. and Chen, H.H. (2014) Cgmp: transition from bench to bedside: a report of the 6th international conference on cgmp generators, effectors and therapeutic implications. Naunyn. Schmiedebergs. Arch. Pharmacol. 387, 707-718
46. Olsen, M.H., Hansen, T.W., Christensen, M.K., Gustafsson, F., Rasmussen, S., Wachtell, K., Borch-Johnsen, K., Ibsen, H., Jørgensen, T. and Hildebrandt, P. (2005) N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46, 660-666
47. Magnusson, M., Jujic, A., Hedblad, B., Engstrom, G., Persson, M., Struck, J., Morgenthaler, N.G., Nilsson, P., Newton-Cheh, C., Wang, T.J. and Melander, O. (2012) Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. J. Clin. Endocrinol. Metab. 97, 638-645
48. Khan, A.M., Cheng, S., Magnusson, M., Larson, M.G., Newton-Cheh, C., McCabe, E.L., Coviello, A.D., Florez, J.C., Fox, C.S., Levy, D. et al. (2011) Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J. Clin. Endocrinol. Metab. 96, 3242-3249
49. Troughton, R.W., Richards, A.M., Yandle, T.G., Frampton, C.M. and Nicholls, M.G. (2007) The effects of medications on circulating levels on circulating levels of cardiac natriuretic peptides. Ann. Med. 39, 242-260
50. Moro, C., Pillard, F., De Glisezinski, I., Harant, I., Riviere, D., Stich, V., Lafontan, M., Crampes, F and Berlan, M. (2005) Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men. Med. Sci. Sports Exerc. 37, 1126-1132
51. Blüher, M. (2014) Are metabolically healthy obese individuals really healthy? Eur. J. Endocrinol. 171, R209-R219
52. McMurray, J.J., Packer, M., Desai, A.S., Gong, J., Lefkowitz, M.P., Rizkala, A.R., Rouleau, J.L., Shi, V.C., Solomon, S.D., Swedberg, K. et al. (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 371, 993-1004
53. Moro, C., Polak, J., Richterova, B., Sengenès, C., Pelikanova, T., Galitzky, J., Stich, V., Lafontan, M. and Berlan, M. (2005) Differential regulation of atrial natriuretic peptide-and adrenergic receptor-dependent lipolytic pathways in human adipose tissue. Metabolism 54, 122-131